Avelumab recommended for metastatic Merkel cell carcinoma in adults

Evidence collected by the Cancer Drugs Fund shows, compared with chemotherapy, avelumab improves how long people have before their disease progresses and how long they live.

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date

Existing members Sign in